Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis

CONCLUSIONS: Low-dose corticosteroids combined with leflunomide are a safe and effective treatment for progressive IgA nephropathy.TRIAL REGISTRATION: The PROSPERO registration number is CRD42022361883.PMID:38468247 | DOI:10.1186/s12894-024-01438-3

Source: Herpes - March 12, 2024 Category: Infectious Diseases Authors: Dongxu Zhang Bowen Xia Xin Zhang Pu Liang Xiaopeng Hu Source Type: research